Kraft Heinz eliminating chemical dyes: What to know
Kraft Heinz, one of the country's largest food and beverage companies, said Tuesday it will stop using artificial dyes in its U.S. products by 2027 and will not launch new products that contain them.
'As a food company with a 150+ year heritage, we are continuously evolving our recipes, products, and portfolio to deliver superiority to consumers and customers,' Kraft Heinz North America President Pedro Navio said in a statement, adding 'the vast majority of our products use natural or no colors.'
The shift will affect about 10 percent of Kraft Heinz products sold — most prominently the company's vibrant Kool-Aid brand drink mixes and Jell-O brand flavored gelatin dessert mixes.
But some of the company's most popular products won't be affected. Kraft Heinz removed artificial colors from Kraft Mac & Cheese products nearly a decade ago, and Heinz Tomato Ketchup has never used artificial dyes, relying instead on tomatoes and spices for its deep red color.
The company outlined what it described as its 'three-pronged approach' to phase out the dyes it still uses: removing unnecessary color additives, replacing artificial colors with natural colors and releasing new colors and shades for products when existing colors can't be replicated with natural ones.
The shift comes amid a growing public aversion to artificial food dyes, including ones that have been approved for use by the U.S. Food and Drug Administration (FDA) for decades, and an anti-dye push from key officials in President Trump's administration.
Consumer research group Civic Science released survey data last month that showed 67 percent of U.S. adults polled said they are concerned about food dyes in what they eat, and several states have approved bans on specific dyes in foods.
Health and Human Services Secretary Robert F. Kennedy Jr. and other officials announced an effort in April to pressure producers to phase out petroleum-based artificial colors.
FDA commissioner Marty Makary cited studies on synthetically altered foods as evidence that vibrant colors produced in foods can 'mess with the child's developing brain to make ultra-processed foods more attractive, even when the child already feels full.'
'These studies have associated food colors directly with obesity and diabetes,' he said.
Kennedy, a long-time critic of food additives, said companies have been responsive to the administration's push to phase them out.
'Food dye is just a no-brainer,' he said. 'We're really happy with the reception; I think they're ready to change the industry.'
Kraft Heinz said it was already pursuing options to rely on more natural alternatives, as displayed in its shifts away from Food, Drug & Cosmetic (FD&C) dyes for other products.
'Above all, we are focused on providing nutritious, affordable, and great-tasting food for Americans and this is a privilege we don't take lightly,' Navio said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
San Francisco Chronicle
29 minutes ago
- San Francisco Chronicle
Texas is leading psychedelic research for treating addiction, mental illness. Where is California?
In recent years, researchers have expressed renewed optimism that psychedelics can be used in therapeutic settings to help treat addiction and mental illness, intertwined crises that have devastated Californians. Yet the Golden State is falling behind Republican-led states like Texas and Indiana in expanding research on these promising therapies. Texas earlier this month agreed to invest $50 million in public funding to research the therapeutic potential of ibogaine, a powerful psychedelic that has shown promise in treating opioid addiction, depression and anxiety. The move by Texas lawmakers was described as one of the largest public investments in psychedelic medicine to date. At his signing ceremony, Texas Gov. Greg Abbott proclaimed that 'Texas is now leading the way in the United States for the evaluation of ibogaine as a potential medication that can help improve the lives of so many Americans." Last year, Indiana Gov. Eric Holcomb signed a law to create a new research fund for therapy using psilocybin, a naturally occurring psychedelic compound found in 'magic mushrooms.' Although the federal government has not approved ibogaine, or most psychedelics, for medical use, there's growing interest among researchers and veteran organizations to explore the therapeutic benefits of drugs like ibogaine, MDMA, LSD, ketamine and psilocybin. Some California organizations have made considerable strides, though there have been roadblocks. San Jose-based Lykos Therapeutics last year became the first company to get a psychedelic compound through the Federal Drug Administration's extensive drug review process for an MDMA-assisted therapy for PTSD but the agency instructed the company to conduct more clinical trials before potential approval. For years, people experiencing addiction and mental illness, including a growing number of veterans and first responders, have quietly traveled to psychedelic-assisted treatment clinics in Mexico. Early research has produced some encouraging results for using these substances to treat addiction and mental illness, including depression, anxiety and post-traumatic stress disorder. Most prominent California universities employ researchers participating in therapeutic psychedelic clinical trials, though they're funded by federal grants, philanthropic donors or private pharmaceutical companies. A 2024 study from Stanford Medicine, for instance, found that ibogaine, when administered safely, improved emotional processing and cognitive functioning in veterans with traumatic brain injuries. The new spotlight on the therapeutic potential of psychedelics comes amid national opioid addiction and mental health crises, where for decades research has lagged. California has not made any public investments to date in researching psychedelic medicine, though there have been several failed attempts in recent years. 'There is growing awareness and support. It just keeps hitting different kinds of walls,' said State Senator Scott Wiener, D- San Francisco, adding that 'California is falling behind.' Gov. Gavin Newsom in 2023 vetoed a bill authored by Wiener to decriminalize the use and possession of certain psychedelics. Newsom called psychedelic medicine 'an exciting frontier' and said that California would be 'on the front edge of leading it,' but urged lawmakers to bring the legislation back the following session with more of a therapeutic focus. Wiener followed Newsom's request and introduced a bill last year with therapeutic guidelines, but it failed in committee. Also in 2023, a Los Angeles-based physician filed paperwork for a $5 billion ballot initiative to create a new state agency for studying the effects of psychedelic-assisted therapy, but it was later withdrawn. Additionally, two other state senators, Josh Becker, D-Menlo Park, and Brian Jones, R-San Diego, sponsored legislation to create a pilot program for veterans and former first responders to access psychedelic treatment for mental health conditions. The measure failed to make it out of the legislature two years in a row. 'I don't know what's going on in California to tell you the truth,' Jones said. 'Senator Becker and I are committed to trying again. It's just a question of how far other states get ahead of us now.' The Texas initiative focuses specifically on research involving ibogaine, a psychedelic compound originating from an African root. Ibogaine was used for centuries in religious ceremonies, but more recently has attracted attention for its antidepressant properties and its apparent ability to reduce opioid cravings and withdrawal. Under the Texas law, the state will invest $50 million in state funds to establish a public-private partnership with a $50 million matching contribution from a drug developer to run FDA-approved clinical trials with ibogaine. The goal is to study its ability to treat opioid use disorder and any co-occurring mental health conditions. The legislation guarantees Texas maintains authority over the research and development and that the state receives at least 20% of profits from any ibogaine pharmaceutical resulting from the trials. David Olson, director of the UC Davis Institute for Psychedelics and Neurotherapeutics, said the investment in Texas was 'very encouraging for the field of psychedelic medicine' but questioned the decision by Texas lawmakers to go all in on ibogaine. 'I would have preferred to see legislation where a variety of different types of substances were considered and then they can move forward with whatever was deemed most appropriate,' Olson said. 'At this moment, there are still so many unanswered questions and we need a lot of basic science across the board.' Although ibogaine has shown some promising results in treating opioid addiction and mental illness, it has also caused heart damage and deaths to several patients. The drug is known to inhibit certain potassium channels, which can lead to cardiac arrhythmias, but ibogaine proponents argue that it can be mitigated through regular supervision, magnesium administration and cardiac monitoring. Researchers believe other psychedelics, notably psilocybin, have shown more efficacy and are closer to gaining approval by the FDA. 'Psychedelics have inherent potential to be of great value to people for whom standard treatments often prove ineffectual,' said Charles Grob, a professor of psychiatry and pediatrics at the UCLA School of Medicine. 'But investigators have to do their due diligence to optimize safety parameters.'
Chicago Tribune
33 minutes ago
- Chicago Tribune
Chicago-based Kraft Heinz pulling artificial dyes from its US products in 2027
Chicago's Kraft Heinz will be pulling artificial dyes from its U.S. products starting in 2027 and will no longer roll out new products with the dyes. The move comes nearly two months after U.S. health officials said that they would urge foodmakers to phase out petroleum-based artificial colors in the nation's food supply. Kraft Heinz said Tuesday that almost 90% of its U.S. products already don't contain food, drug & cosmetic colors, but that the products that do still use the dyes will have them removed by the end of 2027. FD&C colors are synthetic additives that are approved by the U.S. Food and Drug Administration for use in food, drugs and cosmetics. Kraft Heinz said that many of its U.S. products that still use the FD&C colors are in its beverage and desserts categories, including certain products sold under brands including Crystal Light, Kool Aid, Jell-O and Jet Puffed. The company said that it will instead use natural colors for the products. 'The vast majority of our products use natural or no colors, and we've been on a journey to reduce our use of FD&C colors across the remainder of our portfolio,' Pedro Navio, North America President at Kraft Heinz, said in a statement. Kraft Heinz stripped artificial colors, flavors and preservatives from its macaroni and cheese in 2016 and said it has never used artificial dyes in its ketchup. The company plans to work with licensees of its brands to encourage them to remove the dyes. In April Food and Drug Administration Commissioner Marty Makary said at a news conference that the agency would take steps to eliminate the synthetic dyes by the end of 2026, largely by relying on voluntary efforts from the food industry. Health advocates have long called for the removal of artificial dyes from foods, citing mixed studies indicating they can cause neurobehavioral problems, including hyperactivity and attention issues, in some children. The FDA has maintained that the approved dyes are safe and that 'the totality of scientific evidence shows that most children have no adverse effects when consuming foods containing color additives.' The FDA currently allows 36 food color additives, including eight synthetic dyes. In January, the agency announced that the dye known as Red 3 — used in candies, cakes and some medications — would be banned in food by 2027 because it caused cancer in laboratory rats. Artificial dyes are used widely in U.S. foods. In Canada and in Europe — where synthetic colors are required to carry warning labels — manufacturers mostly use natural substitutes. Several states, including California and West Virginia, have passed laws restricting the use of artificial colors in foods. Many U.S. food companies are already reformulating their foods, according to Sensient Colors, one of the world's largest producers of food dyes and flavorings. In place of synthetic dyes, foodmakers can use natural hues made from beets, algae and crushed insects and pigments from purple sweet potatoes, radishes and red cabbage.
New York Post
36 minutes ago
- New York Post
This prescription hair loss gummy is made in pharmacy — and was specifically designed for women
It might be a man's world, but women are losing their locks too. Now there's a sweet way to fight back: Telehealth company Hims & Hers just launched the first-ever clinically proven prescription hair growth gummy made specifically for women battling chronic hair loss, and they promise they've got the FDA to back up what's in their supplement. The Post spoke with Dr. Jessica Shepherd, the company's chief medical officer, to get the lowdown on the brand-new Biotin + Minoxidil Gummy — and why female hair loss is finally getting a moment in the spotlight. Advertisement 5 Hers' Biotin + Minoxidil Gummy combines two hair loving ingredients to support your strands. HERS More than a bad hair day Shedding 50 to 100 strands per day is generally considered normal — but for many, hair loss goes way beyond that. By age 50, about 85% of men and 40% of women experience noticeably thinning hair, according to the American Hair Loss Association. 'Female hair loss usually appears as overall thinning across the scalp, whereas male hair loss typically involves more defined patterns such as a receding hairline or bald spots,' Shepherd told The Post. Advertisement And it's not just grandma's problem. Studies show that 12% of women start losing their hair before they reach 30. Despite the widespread experience, Shepherd said the healthcare industry has historically focused on the source of male-pattern baldness. 'This leaves conditions unique to women, such as polycystic ovarian syndrome, menopause and postpartum hair loss, largely underexplored and misunderstood,' she explained. 'As a result, many women feel unheard and unseen, with their concerns dismissed.' Advertisement 5 Hair loss in women is often treatable, especially when addressed early. Nadya Kolobova – To make matters worse, Shepherd said the link between hair health and overall wellbeing — especially factors like inflammation, stress, nutrition deficiencies and hormone imbalances — often gets ignored, preventing women from getting the full care they need. 'We understand these specific challenges women face and proactively consider how we can make access to quality treatment seamless and convenient,' she said. A gummy game-changer Advertisement Minoxidil — commonly sold under the brand name Rogaine — is the only FDA-approved drug to treat both male and female pattern hair loss. But Shepherd said dosage and application varies due to hormonal and physiological differences between the sexes. That's where Hers' new gummy comes in. 5 The Biotin + Minoxidil gummy is prescription strength. HERS Green apple flavored and prescription-only, it's the first dermatologist-formulated gummy made specifically for women's chronic hair loss. It combines minoxidil for density with biotin for fullness — a double dose of clinically backed hair help. 'Licensed medical providers on the Hers platform can work with you to find the best plan for your hair, including prescribing personalized treatments with clinically proven ingredients based on your needs,' Shepherd said. And unlike messy foams or tough-to-swallow pills, this gummy is designed to be a treat — not a chore. 'The truth is, it doesn't matter how well a medication works if it's not taken consistently,' Shepherd said. 'Our mission was to help women foster adherence through genuine desire, not forced routine.' Advertisement But not all gummies are created equal — in fact, many have been criticized for nutrient inconsistencies and lack of oversight. Shepherd said Hers guarantees quality by manufacturing their gummies in an FDA-regulated pharmacy that follows strict US Pharmacopeia standards. 5 Minoxidil is an ingredient proven to regrow hair in 3-6 months. HERS But does hair grow… everywhere? Minoxidil — whether oral or topical — can sometimes cause unwanted hair growth in places beyond your scalp. The gummy might have the same side effect. Advertisement 'While we know this isn't ideal, shaving, plucking, or waxing should do the trick,' Shepherd said. 'A provider through Hers will review potential side effects with you, address any questions you might have, and provide guidance tailored to your health profile,' she added. More than just hair Hair loss treatments do more than boost your strand count. Advertisement 'When a woman experiences hair loss, the emotional toll can be significant,' Shepherd said. 'They may feel shame, loneliness or isolation and hesitate sharing their struggles, even with loved ones.' One study found that 52% of women feel extreme distress over hair loss — nearly double the 27% of men who said the same. 5 Hair is often deeply intertwined with a woman's sense of self and femininity. blackday – Advertisement The study also showed 53% of women feel less physically attractive and 65% less sexy, compared to just 35% of men. 'We're actively addressing these emotional aspects by fostering a compassionate, supportive community and making these conditions more approachable and treatments more accessible to affirm every woman's unique concerns as valid and important,' Shepherd said. 'We all deserve the ability to feel our best — how we feel inside in turns how we can show up for others, but more importantly, for ourselves,' she continued. Beyond the surface No matter your gender, Shepherd said 'healthy hair begins on the inside.' To prevent thinning and keep hair thick, she recommends a proactive, holistic approach. That means starting before your strands fall out. 'In addition to the right hair care routine using gentle, nourishing products to support a healthy scalp, lifestyle, stress and nutrition are also critical,' Shepherd said. 'Managing stress levels through lifestyle changes like sleep and exercise, and a nutrient-rich diet with enough protein, healthy fats, and vitamins, are crucial to maintaining a healthy head of hair,' she added.
